Standard BioTools Inc.
LAB
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpā¦ read more
Healthcare
Diagnostics & Research
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.87
Price-3.27%
-$0.03
1Y
Price
Market Cap
$339.790m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.-160.0%
EBITDA Margin-177.4%
Net Profit Margin-118.1%
Free Cash Flow Margin-160.0%
EBITDA Margin-177.4%
Net Profit Margin-118.1%
Free Cash Flow MarginRevenue
$86.255m
-26.1%
1y CAGR+15.5%
3y CAGR+5.4%
5y CAGREarnings
-$94.084m
+7.7%
1y CAGR-5.9%
3y CAGR-59.6%
5y CAGREPS
-$0.25
+34.6%
1y CAGR+46.9%
3y CAGR-17.7%
5y CAGRBook Value
$561.123m
$639.114m
Assets$77.991m
Liabilities$29.491m
DebtDebt to Assets
4.6%
-0.3x
Debt to EBITDAFree Cash Flow
-$94.483m
+35.2%
1y CAGR-47.8%
3y CAGR-51.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company